Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by DeathXray33on Oct 21, 2024 9:07am
192 Views
Post# 36274462

RE:RE:Pre-BTD week?

RE:RE:Pre-BTD week?
Lesalpes29 wrote: On the bid this morning.
Time to add some more. GL


"The latest research now demonstrates that Ruvidar TM is more potent than Acyclovir, the gold-standard anti-herpetic treatment, in destroying an ongoing HSV-1 infection." ------------------------------------------------------------"Another very important observation from the experiment is that Acyclovir was unable to prevent HSV-1 replication, if added one day after infection; however, Ruvidar TM was able to prevent HSV-1 replication by 10 million-fold when added 1 day after infection." ------------------------------------------------------------"In other words, from a clinical perspective, if a patient has pre-existing HSV-1, then Acyclovir would be unable to prevent replication of the virus; however, Ruvidar TM would be extremely effective."
<< Previous
Bullboard Posts
Next >>